DrugPatentWatch Database Preview

Dr Reddys Labs Inc Company Profile

« Back to Dashboard

What is the competitive landscape for DR REDDYS LABS INC, and when can generic versions of DR REDDYS LABS INC drugs launch?

DR REDDYS LABS INC has forty approved drugs.

There are five US patents protecting DR REDDYS LABS INC drugs. There are two tentative approvals on DR REDDYS LABS INC drugs.

There are ninety-three patent family members on DR REDDYS LABS INC drugs in forty-eight countries and eighty-three supplementary protection certificates in thirteen countries.

Summary for Dr Reddys Labs Inc

International Patents:	93
US Patents:	5
Tradenames:	33
Ingredients:	25
NDAs:	40

Drugs and US Patents for Dr Reddys Labs Inc

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dr Reddys Labs Inc	PRAVASTATIN SODIUM	pravastatin sodium	TABLET;ORAL	076714-003	Oct 23, 2006	AB	RX	No	No
Dr Reddys Labs Inc	LAROTID	amoxicillin	FOR SUSPENSION;ORAL	062226-004	Approved Prior to Jan 1, 1982	AB	RX	No	No
Dr Reddys Labs Inc	AUGMENTIN '400'	amoxicillin; clavulanate potassium	FOR SUSPENSION;ORAL	050725-002	May 31, 1996		DISCN	Yes	No
Dr Reddys Labs Inc	AUGMENTIN '875'	amoxicillin; clavulanate potassium	TABLET;ORAL	050720-001	Feb 13, 1996	AB	RX	Yes	No

Paragraph IV (Patent) Challenges for DR REDDYS LABS INC drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Extended-release Tablets	1000 mg/62.5 mg		2009-01-21

Non-Orange Book US Patents for Dr Reddys Labs Inc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
6,294,199	Method of treating a bacterial infection comprising administering amoxycillin
6,660,299	Modified release pharmaceutical formulation comprising amoxycillin

International Patents for Dr Reddys Labs Inc Drugs

Country	Document Number	Estimated Expiration
Netherlands	1014915
Germany	10017883
United Kingdom	2351661
Japan	2002541186

Supplementary Protection Certificates for Dr Reddys Labs Inc Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2012000051	Germany		PRODUCT NAME: KOMBINATIONSPRODUKT UMFASSEND NAPROXEN UND ESOMEPRAZOL-MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 85145.00.00 20120202; FIRST REGISTRATION: GROSSBRITANNIEN PL 17901/0263 - 0001 20101105
77; 5006-2008	Slovakia		PRODUCT NAME: SITAGLIPTIN A METFORMIN; REGISTRATION NO/DATE: EU/1/08/455/001-014 20080716
5006-2008	Slovakia		PRODUCT NAME: SITAGLIPTIN A METFORMIN; NAT. REG.NO/DATE: EU/1/08/455/001-014, EU/1/08/456/001-014, EU/1/08/457/001-014 20080716; FIRST REG.:CH 58450 01-03 20080408
C0040	France		PRODUCT NAME: EZETIMIBE; SIMVASTATINE; NAT. REGISTRATION NO/DATE: NL 31849 20050728; FIRST REGISTRATION: DE - 58 878 00 00 20040402

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Dr Reddys La
• Dr Reddys Labs Inc
• Dr Reddys Labs Ltd
• Dr Reddys Labs Sa